Kai Lin

Kai Lin Email and Phone Number

Chief Scientific Officer @ HEC Pharm Co., Ltd.
Boston, MA, US
Kai Lin's Location
Belmont, Massachusetts, United States, United States
About Kai Lin

• 20+ years of drug discovery & development experience in pharmaceutical industry that led to 16 INDs and 2 NDAs • Led both small molecule and biologics drug development, including siRNA, antibody, and protein therapeutics• Built and managed multiple high-performing research and cross-functional teams• Experienced in managing external partnership, academic collaboration and CROs • Played major roles in developing therapeutic strategies and in-/out-licensing • Involved in Phase 1-3 clinical trial design, protocol review and study support• Closely interacted with KOLs and regulatory agencies including FDA and EMA• Authored 50 peer-reviewed papers/book chapters and listed as inventors on 30+ patents

Kai Lin's Current Company Details
HEC Pharm Co., Ltd.

Hec Pharm Co., Ltd.

View
Chief Scientific Officer
Boston, MA, US
Website:
hecpharm.com
Employees:
129
Kai Lin Work Experience Details
  • Hec Pharm Co., Ltd.
    Chief Scientific Officer
    Hec Pharm Co., Ltd.
    Boston, Ma, Us
  • Aerium Therapeutics
    Senior Vice President, Head Of Research
    Aerium Therapeutics Jun 2022 - Present
    Boston, Ma, Us
    Responsible for both monoclonal antibody and small molecule drug discoveriesAER001/002 (Ph1)
  • Atea Pharmaceuticals, Inc
    Vice President
    Atea Pharmaceuticals, Inc Nov 2020 - Jun 2022
    Boston, Massachusetts, Us
    COVID-19, Dengue, RSVAT-527 (Ph3), AT-752 (Ph1)
  • Enanta Pharmaceuticals
    Senior Director
    Enanta Pharmaceuticals Jan 2015 - Nov 2020
    Watertown, Ma, Us
    Respiratory infections, liver diseasesEDP-938 (Ph2), EDP-514 (Ph2), EDP-721 (Ph1), EDP-235 (Ph1), EDP-323
  • Idenix Pharmaceuticals, Inc. (Acquired By Merck & Co.)
    Executive Director, Biology And Translational Science
    Idenix Pharmaceuticals, Inc. (Acquired By Merck & Co.) May 2014 - Dec 2014
    Virology, oncologyUprifosbuvir/MK-3682 (Ph2)
  • Permeon Biologics, Inc, A Flagship Company
    Director Of Biology
    Permeon Biologics, Inc, A Flagship Company Jun 2012 - May 2014
    Antibody-drug conjugates (ADC), protein therapeuticsOncology, rare diseases
  • Novartis, Cambridge, Massachusetts, Usa
    Senior Investigator Ii, Group Head (2006-2012), Lab Head (2004-2006)
    Novartis, Cambridge, Massachusetts, Usa May 2004 - Jun 2012
    Basel, Baselstadt, Ch
    • Built and managed a research group of 14 PhD and non-PhD scientists • Led multiple cross-functional project teams that involved chemistry, biology, DMPK, toxicology, CMC and TM• Closely interacted with health authorities (FDA, EMA and sFDA) and KOLs• Played a major role in developing portfolio and evaluating in-licensing opportunities• Managed external partnership, academic collaboration and CROs• Tyzeka/Sebivo/Telbivudine (NDA), alisporivir/Debio-025 (Ph3), NIM811 (Ph2), NM-282 (Ph2), EDP-239 (Ph2), BZF961 (Ph1), LDI133, RSV604 (Ph2)
  • Vertex Pharmaceuticals, Inc., Cambridge, Massachusetts, Usa
    Staff Investigator (2002-2004), Investigator (2000-2002)
    Vertex Pharmaceuticals, Inc., Cambridge, Massachusetts, Usa Jan 2000 - May 2004
    Boston, Ma, Us
    • Responsible for biology support for the HCV protease program - a key contributor to the discovery of Incivek/Telaprevir/VX-950, the first approved antiviral drug for HCV• Involved in multiple kinase programs for oncology indications: established in vitro and cell-based kinase assays and performed signal transduction and cell cycle analysis • Provided preclinical support for the development of IMPDH inhibitors, Merimepodib/VX-497 (Ph2), VX-944 (Ph1)
  • University Of Pennsylvania
    Postdoctoral Fellow
    University Of Pennsylvania 1999 - 2000
    Philadelphia, Pa, Us
    • Designed and optimized novel in vitro assays for high-throughput screening of natural products in collaboration with National Cancer Institute

Kai Lin Education Details

  • University Of Pennsylvania
    University Of Pennsylvania
    Biochemistry
  • Nankai University
    Nankai University
    Biochemistry
  • Nankai High School
    Nankai High School
    High School Diploma

Frequently Asked Questions about Kai Lin

What company does Kai Lin work for?

Kai Lin works for Hec Pharm Co., Ltd.

What is Kai Lin's role at the current company?

Kai Lin's current role is Chief Scientific Officer.

What schools did Kai Lin attend?

Kai Lin attended University Of Pennsylvania, Nankai University, Nankai High School.

Who are Kai Lin's colleagues?

Kai Lin's colleagues are 任青云, 刘冲刘冲, Yanjun Wu, 王海媚, 周雪娇, Sky Sun, 杨凤智.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.